GeneDx Holdings (WGS) Enterprise Value (2020 - 2026)

GeneDx Holdings has disclosed Enterprise Value across 7 years of filings, most recently posting -$170.7 million for Q1 2026.

• In Q1 2026, Enterprise Value fell 7.24% year-over-year to -$170.7 million; the TTM figure through Mar 2026 stood at -$170.7 million (down 7.24% YoY), while the FY2025 annual figure was -$171.3 million, down 21.32% from the prior year.
• Enterprise Value held at -$170.7 million in Q1 2026, from -$171.3 million in the prior quarter.
• Over the last five years, Enterprise Value for WGS reached as high as -$106.9 million in Q2 2024 and fell as low as -$315.0 million in Q1 2022.
• The 5-year median for Enterprise Value is -$155.1 million (2025), against an average of -$164.6 million.
• The widest YoY moves for Enterprise Value: up 69.06% in 2022, down 973.92% in 2022.
• A 5-year view of Enterprise Value shows it stood at -$123.9 million in 2022, then retreated by 5.01% to -$130.1 million in 2023, then dropped by 8.48% to -$141.2 million in 2024, then fell by 21.32% to -$171.3 million in 2025, then climbed by 0.35% to -$170.7 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$170.7 million, -$171.3 million, and -$155.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.